共 50 条
- [21] Switching from intravenous to subcutaneous VEDOlizumab formulation in ulcerative colitis patients in clinical remission: the SVEDO Study, a multicenter IG-IBD study JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1176 - I1176
- [22] Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE study JOURNAL OF CROHNS & COLITIS, 2019, 13 : S9 - S9